Bukwang Pharmaceutical disclosed Tuesday that its second-quarter consolidated operating profit fell 30 percent year-on-year to 1.41 billion won ($951,000).

Revenue for the same period rose 33.8 percent to 56.99 billion won.

Net profit for the period came in at a preliminary 1.39 billion won, down 78.3 percent from a year earlier.


jiyoon436@heraldcorp.com